The blood-borne miRNA signature of lung cancer patients is independent of histology but influenced by metastases

Molecular Cancer

Volumn 13, Issue 1, 2014, Pages

  Leidinger, Petra ^a   Backes, Christina ^b   Blatt, Michael ^a   Keller, Andreas ^b   Huwer, Hanno ^c   Lepper, Philipp ^a   Bals, Robert ^a   Meese, Eckart ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c Voelklingen Heart Centre   (Germany)

Author keywords

Adenocarcinoma; Blood; Expression profile; Histology; Lung cancer; Metastasis; Microarray; MicroRNA; Non small cell lung cancer; Small cell lung cancer; Squamous cell lung cancer

Indexed keywords

CIGARETTE SMOKE; MICRORNA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER PROGNOSIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE SEQUENCE; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MICROARRAY ANALYSIS; RNA ANALYSIS; SMALL CELL LUNG CANCER; SQUAMOUS CELL LUNG CARCINOMA; ADENOCARCINOMA; BLOOD; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; MIDDLE AGED; PATHOLOGY; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; AGED; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS, SQUAMOUS CELL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 84949115812     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-13-202     Document Type: Article

References (44)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127:2893-2917. 10.1002/ijc.25516
2. Grilley-Olson JE, Hayes DN, Moore DT, Leslie KO, Wilkerson MD, Qaqish BF, Hayward MC, Cabanski CR, Yin X, Socinski MA, Stinchcombe TE, Thorne LB, Allen TC, Banks PM, Beasley MB, Borczuk AC, Cagle PT, Christensen R, Colby TV, Deblois GG, Elmberger G, Graziano P, Hart CF, Jones KD, Maia DM, Miller CR, Nance KV, Travis WD, Funkhouser WK: Validation of interobserver agreement in lung cancer assessment: hematoxylin-eosin diagnostic reproducibility for non-small cell lung cancer: the 2004 world health organization classification and therapeutically relevant subsets. Arch Pathol Lab Med 2012, 137:32-40.
3. Scott WJ, Howington J, Feigenberg S, Movsas B, Pisters K, American College of Chest P: Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007, 132:234S-242S. 10.1378/chest.07-1378
4. Lackey A, Donington JS: Surgical management of lung cancer. Semin Intervent Radiol 2013, 30:133-140. 10.1055/s-0033-1342954
5. Scheff RJ, Schneider BJ: Non-small-cell lung cancer: treatment of late stage disease: chemotherapeutics and new frontiers. Semin Intervent Radiol 2013, 30:191-198. 10.1055/s-0033-1342961
6. Rossi G, Pelosi G, Barbareschi M, Graziano P, Cavazza A, Papotti M: Subtyping non-small cell lung cancer: relevant issues and operative recommendations for the best pathology practice. Int J Surg Pathol 2013, 21:326-336. 10.1177/1066896913489346
7. Feinstein AR, Gelfman NA, Yesner R: Observer variability in the histopathologic diagnosis of lung cancer. Am Rev Respir Dis 1970, 101:671-684.
8. Stang A, Pohlabeln H, Muller KM, Jahn I, Giersiepen K, Jockel KH: Diagnostic agreement in the histopathological evaluation of lung cancer tissue in a population-based case-control study. Lung Cancer 2006, 52:29-36. 10.1016/j.lungcan.2005.11.012
9. Dragan AM, Rosca E, Vaida T: Correlations between the results of the histological and cytological examination in the diagnostic of the broncho-pulmonary cancer. Rom J Morphol Embryol 2005, 46:311-315.
10. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR: MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838. 10.1038/nature03702
11. Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, Zepeniuk M, Benjamin H, Shabes N, Tabak S, Levy A, Lebanony D, Goren Y, Silberschein E, Targan N, Ben-Ari A, Gilad S, Sion-Vardy N, Tobar A, Feinmesser M, Kharenko O, Nativ O, Nass D, Perelman M, Yosepovich A, Shalmon B, Polak-Charcon S, Fridman E, Avniel A, Bentwich I, Bentwich Z, et al.: MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol 2008, 26:462-469. 10.1038/nbt1392
12. Fassina A, Cappellesso R, Fassan M: Classification of non-small cell lung carcinoma in transthoracic needle specimens using microRNA expression profiling. Chest 2011, 140:1305-1311. 10.1378/chest.11-0708
13. Huang W, Hu J, Yang DW, Fan XT, Jin Y, Hou YY, Wang JP, Yuan YF, Tan YS, Zhu XZ, Bai CX, Wu Y, Zhu HG, Lu SH: Two microRNA panels to discriminate three subtypes of lung carcinoma in bronchial brushing specimens. Am J Respir Crit Care Med 2012, 186:1160-1167. 10.1164/rccm.201203-0534OC
14. Gilad S, Lithwick-Yanai G, Barshack I, Benjamin S, Krivitsky I, Edmonston TB, Bibbo M, Thurm C, Horowitz L, Huang Y, Feinmesser M, Hou JS, St Cyr B, Burnstein I, Gibori H, Dromi N, Sanden M, Kushnir M, Aharonov R: Classification of the four main types of lung cancer using a microRNA-based diagnostic assay. J Mol Diagn 2012, 14:510-517. 10.1016/j.jmoldx.2012.03.004
15. Du L, Schageman JJ, Irnov Girard L, Hammond SM, Minna JD, Gazdar AF, Pertsemlidis A: MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs. J Exp Clin Cancer Res 2010, 29:75. 10.1186/1756-9966-29-75
16. Shen J, Stass SA, Jiang F: MicroRNAs as potential biomarkers in human solid tumors. Cancer Lett 2012, 329:125-136.
17. Russo F, Di Bella S, Nigita G, Macca V, Lagana A, Giugno R, Pulvirenti A, Ferro A: miRandola: extracellular circulating microRNAs database. PLoS One 2012, 7:e47786. 10.1371/journal.pone.0047786
18. Shah MY, Calin GA: The Mix of Two Worlds: Non-Coding RNAs and Hormones. Nucleic Acid Ther 2012, 23:2-8.
19. Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA: MicroRNAs in body fluids-the mix of hormones and biomarkers. Nat Rev Clin Oncol 2011, 8:467-477. 10.1038/nrclinonc.2011.76
20. Etheridge A, Lee I, Hood L, Galas D, Wang K: Extracellular microRNA: a new source of biomarkers. Mutat Res 2011, 717:85-90. 10.1016/j.mrfmmm.2011.03.004
21. Cortez MA, Calin GA: MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin Biol Ther 2009, 9:703-711. 10.1517/14712590902932889
22. Keller A, Backes C, Leidinger P, Kefer N, Boisguerin V, Barbacioru C, Vogel B, Matzas M, Huwer H, Katus HA, Stahler C, Meder B, Meese E: Next-generation sequencing identifies novel microRNAs in peripheral blood of lung cancer patients. Mol Biosyst 2011, 7:3187-3199. 10.1039/c1mb05353a
23. Keller A, Leidinger P, Bauer A, Elsharawy A, Haas J, Backes C, Wendschlag A, Giese N, Tjaden C, Ott K, Werner J, Hackert T, Ruprecht K, Huwer H, Huebers J, Jacobs G, Rosenstiel P, Dommisch H, Schaefer A, Muller-Quernheim J, Wullich B, Keck B, Graf N, Reichrath J, Vogel B, Nebel A, Jager SU, Staehler P, Amarantos I, Boisguerin V, et al.: Toward the blood-borne miRNome of human diseases. Nat Methods 2011, 8:841-843. 10.1038/nmeth.1682
24. Keller A, Leidinger P, Borries A, Wendschlag A, Wucherpfennig F, Scheffler M, Huwer H, Lenhof HP, Meese E: miRNAs in lung cancer - studying complex fingerprints in patient's blood cells by microarray experiments. BMC Cancer 2009, 9:353. 10.1186/1471-2407-9-353
25. Keller A, Leidinger P, Gislefoss R, Haugen A, Langseth H, Staehler P, Lenhof HP, Meese E: Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis. RNA Biol 2011, 8:506-516. 10.4161/rna.8.3.14994
26. Leidinger P, Keller A, Borries A, Huwer H, Rohling M, Huebers J, Lenhof HP, Meese E: Specific peripheral miRNA profiles for distinguishing lung cancer from COPD. Lung Cancer 2011, 74:41-47. 10.1016/j.lungcan.2011.02.003
27. Leidinger P, Keller A, Backes C, Huwer H, Meese E: MicroRNA expression changes after lung cancer resection: a follow-up study. RNA Biol 2012, 9:900-910. 10.4161/rna.20107
28. Jeong HC, Kim EK, Lee JH, Lee JM, Yoo HN, Kim JK: Aberrant expression of let-7a miRNA in the blood of non-small cell lung cancer patients. Mol Med Report 2011, 4:383-387.
29. Patnaik SK, Kannisto E, Mallick R, Yendamuri S: Overexpression of the lung cancer-prognostic miR-146b microRNAs has a minimal and negative effect on the malignant phenotype of A549 lung cancer cells. PLoS One 2011, 6:e22379. 10.1371/journal.pone.0022379
30. Landi MT, Zhao Y, Rotunno M, Koshiol J, Liu H, Bergen AW, Rubagotti M, Goldstein AM, Linnoila I, Marincola FM, Tucker MA, Bertazzi PA, Pesatori AC, Caporaso NE, McShane LM, Wang E: MicroRNA expression differentiates histology and predicts survival of lung cancer. Clin Cancer Res 2010, 16:430-441. 10.1158/1078-0432.CCR-09-1736
31. Lebanony D, Benjamin H, Gilad S, Ezagouri M, Dov A, Ashkenazi K, Gefen N, Izraeli S, Rechavi G, Pass H, Nonaka D, Li J, Spector Y, Rosenfeld N, Chajut A, Cohen D, Aharonov R, Mansukhani M: Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. J Clin Oncol 2009, 27:2030-2037. 10.1200/JCO.2008.19.4134
32. Del Vescovo V, Cantaloni C, Cucino A, Girlando S, Silvestri M, Bragantini E, Fasanella S, Cuorvo LV, Palma PD, Rossi G, Papotti M, Pelosi G, Graziano P, Cavazza A, Denti MA, Barbareschi M: miR-205 Expression levels in nonsmall cell lung cancer do not always distinguish adenocarcinomas from squamous cell carcinomas. Am J Surg Pathol 2011, 35:268-275. 10.1097/PAS.0b013e3182068171
33. Zhang YK, Zhu WY, He JY, Chen DD, Huang YY, Le HB, Liu XG: miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes. J Cancer Res Clin Oncol 2012, 138:1641-1650. 10.1007/s00432-012-1240-0
34. Bishop JA, Benjamin H, Cholakh H, Chajut A, Clark DP, Westra WH: Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach. Clin Cancer Res 2010, 16:610-619. 10.1158/1078-0432.CCR-09-2638
35. Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y, Chen Y, Xu L, Zen K, Zhang C, Shen H: Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 2010, 28:1721-1726. 10.1200/JCO.2009.24.9342
36. Lin Q, Mao W, Shu Y, Lin F, Liu S, Shen H, Gao W, Li S, Shen D: A cluster of specified microRNAs in peripheral blood as biomarkers for metastatic non-small-cell lung cancer by stem-loop RT-PCR. J Cancer Res Clin Oncol 2012, 138:85-93. 10.1007/s00432-011-1068-z
37. Kanitz A, Imig J, Dziunycz PJ, Primorac A, Galgano A, Hofbauer GF, Gerber AP, Detmar M: The expression levels of microRNA-361-5p and its target VEGFA are inversely correlated in human cutaneous squamous cell carcinoma. PLoS One 2012, 7:e49568. 10.1371/journal.pone.0049568
38. Arora S, Ranade AR, Tran NL, Nasser S, Sridhar S, Korn RL, Ross JT, Dhruv H, Foss KM, Sibenaller Z, Ryken T, Gotway MB, Kim S, Weiss GJ: MicroRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration. Int J Cancer 2011, 129:2621-2631. 10.1002/ijc.25939
39. Chen HY, Lin YM, Chung HC, Lang YD, Lin CJ, Huang J, Wang WC, Lin FM, Chen Z, Huang HD, Shyy JY, Liang JT, Chen RH: miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. Cancer Res 2012, 72:3631-3641. 10.1158/0008-5472.CAN-12-0667
40. Sobin LH, Gospodarowicz MK, Wittekind C: UICC TNM Classification of Malignant Tumours. 7th edition. New York: Wiley-Blackwell, 2009.
41. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I: Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001, 125:279-284. 10.1016/S0166-4328(01)00297-2
42. Hochberg Y: A sharper bonferroni procedure for multiple tests of significance. Biogeosciences 1988, 75:185-193.
43. Vapnik V: The Nature of Statistical Learning Theory. 2nd edition. New York: Springer; 2000.
44. Team R: R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing; 2008.